| abstract |
Methods for diagnosing hematopoietic toxicity include: a) measuring the amount of one or more biomarkers in a test sample of a subject suspected of experiencing hematopoietic toxicity, and (b) comparing the amount measured in step (a) And diagnosing hematopoietic toxicity. Methods and kits for determining how a compound can induce such hematopoietic toxicity in a subject, identifying a therapeutic drug for hematopoietic toxicity, and diagnosing hematopoietic toxicity are also described. |